Gotham Makker, Director at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 29,978 shares at $21.14 ($631K) on 2023-09-29, disclosed to the SEC on 2023-10-02.
Open-market sale of $631k RCKT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.03 | 10,312 | $217K | 34.3% |
| 2 | $21.03 | 10,312 | $217K | 34.3% |
| 3 | $21.14 | 4,677 | $99K | 15.7% |
| 4 | $21.14 | 4,677 | $99K | 15.7% |
| Total | $21.06 avg | 29,978 | $631K | 100% |
| Filing → |
| RCKT | SELL | 2021-06-21 | $3.3M | — | Filing → |